What do you know about monogenic and polygenic autoinflammatory diseases? Join Drs Liebowitz and Mehta as they review the challenges of these conditions. https://t.co/z0mTZEwFkP https://t.co/LAxl2eFZKR

QD Clinic - RA, SSZ, & MI RA with a myocardial inflarction - which DMARD? https://t.co/9o83xedJ3j https://t.co/P5jmZAZ9rt

Join us this weekend! More than 25 sessions on topics ranging from spondyloarthritis, PsA, vasculitis and lupus to JAK inhibitors, RA, artificial intelligence and myositis. CME and MOC offered. Learn more about our program and registration options today! https://t.co/Iac2T2Kohs https://t.co/zu1WJLOcmh

Methotrexate Nodulosis How good (or not) are rheumatologists and what to do about MTX nodulosis? https://t.co/Ot9UfpH68N https://t.co/JQ2AtuE7NV

11-yr French study of #RA Pregnancies: more adverse Preg outcomes in RA, esp w/ active Dz. 11.8K RA vs 10.4 million non-RA Pregs. 75% live births in RA. RA had more preterm(aOR 1.84), low birth wt (1.65), C-Sect (1.46), hospz (1.30), & prematurity (2.02)https://t.co/v9CmiPkIBG https://t.co/S0siiuG0oZ

Mexico survey of 250 RA pts -- 92% used complementary (CAM) therapies - mostly: herbals (65%), homeopathy (64%), cannabis derivatives (51%). Poor DMARD adherence assoc w/ age (p=0.019), comorbidities (p=0.047), CAM use (p = 0.042) (OR 2.84) https://t.co/EGxyIVCMnk https://t.co/jjF5cH53we

FDA Safety Warning: denosumab now has a Boxed Warning for risk of severe hypocalcemia in CKD pts taking Prolia (usually seen 2-10 wks post injx). Pts may or may not be symptomatic. CKD pts should have Ca and Creatinine monitored. https://t.co/tGiG35cOnv https://t.co/ITOZneGKtb

Rheumatologists and the Early Diagnosis of Spondyloarthritis SPACE study of adults referred to rheumatology with less than 2 years of chronic back pain (CBP), shows that only one-third can be reliably diagnosed with axial spondyloarthritis (axSpA). https://t.co/EwrrunyZs7. https://t.co/T0OqlsuU2P

Rituximab Efficacy in MAINRITSAN Long-Term Studies https://t.co/z16uMDihV4 https://t.co/BaWFcwDbYL

Sodium Channels, Carbemazepine and Osteoarthritis Progression A study published in Nature suggests that therapies affecting sodium channels could be employed to treat osteoarthritis. https://t.co/hmzKsgb3gA https://t.co/WVgk8nD4ne

You can still attend RheumNow Live! Below is a preview of one of our "STEP" talks - by Mike Putman, MD, who brings his vast knowledge to the forefront, shedding light on Myths & Mistakes on ANCA-Associated Vasculitis. https://t.co/LzcVytLDij Register: https://t.co/NWXKNhQzc5 https://t.co/ogAfTtH5Nk